Hualan Biological Vaccine Inc. (SHE:301207)

Hualan Biological Vaccine Ratios and Metrics

Market cap in millions CNY. Fiscal year is January - December.

Fiscal Year	Current	FY 2024	FY 2023	FY 2022	FY 2021	FY 2020
Period Ending	Apr 24, 2025	Dec 31, 2024	Dec 31, 2023	Jan 1, 2023	Jan 1, 2022	Dec 31, 2020
Market Capitalization	9,353	10,418	16,680	17,832	-	-
Market Cap Growth	-37.54%	-37.54%	-6.46%	-	-	-
Enterprise Value	6,427	8,180	14,346	15,905	-	-
Last Close Price	15.72	17.51	26.92	28.61	-	-
PE Ratio	45.75	50.69	19.40	34.32	-	-
Forward PE	14.69	9.86	15.22	17.00	-	-
PS Ratio	8.29	9.24	6.92	9.77	-	-
PB Ratio	1.56	1.73	2.66	3.24	-	-
P/TBV Ratio	1.56	1.74	2.67	3.26	-	-
P/FCF Ratio	22.46	25.02	20.21	90.98	-	-
P/OCF Ratio	19.98	22.26	18.78	61.78	-	-
EV/Sales Ratio	5.70	7.25	5.95	8.71	-	-
EV/EBITDA Ratio	27.35	34.81	14.03	24.91	-	-
EV/EBIT Ratio	67.91	86.43	16.27	31.55	-	-
EV/FCF Ratio	15.43	19.64	17.38	81.14	-	-
Debt / Equity Ratio	0.05	0.05	0.05	0.06	0.18	0.09
Debt / EBITDA Ratio	1.28	1.28	0.29	0.47	0.68	0.18
Debt / FCF Ratio	0.72	0.72	0.36	1.53	-	1.24
Asset Turnover	0.14	0.14	0.32	0.32	0.45	0.89
Inventory Turnover	1.50	1.50	2.24	2.69	4.64	5.71
Quick Ratio	3.19	3.19	2.73	2.57	1.43	1.65
Current Ratio	3.40	3.40	3.10	2.73	1.51	1.70
Return on Equity (ROE)	3.35%	3.35%	14.63%	12.51%	24.86%	53.63%
Return on Assets (ROA)	0.76%	0.76%	7.32%	5.43%	10.28%	24.23%
Return on Capital (ROIC)	0.92%	0.92%	8.92%	6.92%	14.75%	36.13%
Return on Capital Employed (ROCE)	1.60%	1.60%	14.00%	9.10%	23.60%	48.10%
Earnings Yield	2.20%	1.97%	5.16%	2.91%	-	-
FCF Yield	4.45%	4.00%	4.95%	1.10%	-	-
Dividend Yield	1.28%	1.14%	2.23%	0.70%	-	-
Payout Ratio	162.67%	162.67%	13.95%	17.49%	2.06%	0.50%
Buyback Yield / Dilution	0.71%	0.71%	-2.03%	-9.33%	-0.01%	0.24%
Total Shareholder Return	1.99%	1.86%	0.20%	-8.63%	-0.01%	0.24%

Updated Oct 29, 2024. Source: S&P Global Market Intelligence. Standard template. Financial Sources.